Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
5
×
venture capital
5
×
wisconsin blog main
wisconsin top stories
celgene
gene editing
ipo
biogen
cancer
fda
novartis
scott gottlieb
abbvie
amgen
apremilast
What
bio
roundup
5
×
ipo
new
abbvie’s
activity
allogene
approvals
barbecuing
becker
billions
biogen
biopharma
camping
cancer
car
cardiologist
celgene
center
check
cholesterol
clamped
colleagues
conference
covid
crispr
day
delays
developing
diversity
dollars
eaton
economic
exome
fast
fda
flop
gene
government
health
Language
unset
Current search:
vc
×
roundup
×
" venture capital "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More